Transmedics Group Inc. (tmdx 1.5 06/01/28)
13F holders, Q1 2026 (March 31)2holders
1new positions
1sold out
$897.15avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Transmedics Group Inc. (tmdx 1.5 06/01/28) in their 13F filings, unchanged from Q4 2025. 1 opened new positions and 1 sold out. The largest holders were Boussard & Gavaudan Investment Management LLP ($5.2M) and Loomis Sayles & Co. L P ($196K).
- Company
- Transmedics Group Inc. (tmdx 1.5 06/01/28)
- CUSIP
- 89377MAB5
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5.2M |
| Exits | 1 | $226K |
All 13F filers, Q4 2025 → Q1 2026: 5,117 shares bought and 150,000 shares sold, net −144,883 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Boussard & Gavaudan Investment Management LLP | 1.23% | New | 4,000 | $5.2M |
| Loomis Sayles & Co. L P | 0.00% | Add +131.3% | 1,968 | $196K |
"% of holder's portfolio" is TRANSMEDICS GROUP INC (TMDX 1.5 06/01/28)'s weight in each manager's 13F, not the share of Transmedics Group Inc. (tmdx 1.5 06/01/28) the manager owns.